Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Makiko, Ika"'
Autor:
Sadahiro Ito, Mamika Ohara, Shogo Sakasai, Shinji Endo, Hiroshi Abe, Kiichiro Yoza, Makiko Ika, Keizo Kato, Yuhi Sakamoto, Shohei Shimizu, Takeshi Yonezawa
Publikováno v:
Kanzo. 62:129-135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8311efa02e782373a2e86ec15e2c5630
https://doi.org/10.2957/kanzo.62.129
https://doi.org/10.2957/kanzo.62.129
Autor:
Sadahiro Itoh, Asami Izu, Takeshi Yonezawa, Yoshiyuki Sato, Keizo Kato, Shohei Shimizu, Ryota Matsuo, Masahiko Sugitani, Makiko Ika, Shinji Endo, Akihito Tsubota, Hiroshi Abe, Hiroshi Hano, Junya Fukuzawa, Noriko Hanawa
Publikováno v:
Clinical journal of gastroenterology. 11(5)
A 32-year-old Japanese woman was admitted to our hospital for the diagnosis and treatment of multiple liver tumors. She had been receiving 125 mg testosterone enanthate every 2 weeks following female-to-male gender identity disorder (GID) diagnosis a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba75379ab93e0c560969a1c3d45d062a
https://pubmed.ncbi.nlm.nih.gov/29589251
https://pubmed.ncbi.nlm.nih.gov/29589251
Autor:
Choitsu Sakamoto, Tatsuya Ide, Makiko Ika, Takashi Kumada, Noritomo Shimada, Kai Yoshizawa, Yoshiyuki Sato, Hiroshi Abe, Yoshimichi Chuganji, Keizo Kato, Koichi Takaguchi, Masanori Atsukawa, Yoshio Aizawa, Akihito Tsubota, Hidenori Toyoda, Michio Sata
Publikováno v:
Hepatology Research. 44:E386-E396
Aim The sustained virological response (SVR) rate of non-responders to peginterferon and ribavirin therapy (PR) is low for 24-week telaprevir-based triple combination therapy (T12PR24), compared to that of treatment-naive patients or previous-treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e6c806c11ba940921cc0f06db2928f3
https://doi.org/10.1111/hepr.12323
https://doi.org/10.1111/hepr.12323
Autor:
Keizo Kato, Makiko Ika, Hiroshi Abe, Keisuke Nagatsuma, Yoshio Aizawa, Tomokazu Matsuura, Akihito Tsubota, Hiroshi Matsudaira, Masanori Atsukawa, Noritomo Shimada
Publikováno v:
Journal of Gastroenterology and Hepatology. 29:144-150
Background and Aim The aim of this study was to clarify which or how factors could influence the probability of sustained virological response (SVR) in 24-week telaprevir-based triple combination therapy for East Asian chronic hepatitis C patients in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92a83f723ddd24f7689536efa021b53b
https://doi.org/10.1111/jgh.12402
https://doi.org/10.1111/jgh.12402
Autor:
Noritomo Shimada, Choitsu Sakamoto, Yoshiyuki Sato, Chisa Kondo, Makiko Ika, Keizo Kato, Akihito Tsubota, Masanori Atsukawa, Yasuhito Tanaka, Hiroshi Abe, Yoshio Aizawa
Publikováno v:
Journal of Medical Virology. 86:461-472
Even when treated with telaprevir-based triple therapy, some patients fail to achieve a sustained virological response. This study identified factors related closely to treatment failure. A total of 146 Japanese genotype 1b chronic hepatitis C patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e3ca98f062307929c04a6d67e365866
https://doi.org/10.1002/jmv.23824
https://doi.org/10.1002/jmv.23824
Autor:
Satoshi Sutoh, Kai Yoshizawa, Akihito Tsubota, Tamihiro Miyazaki, Makiko Ika, Nobuyoshi Seki, Hiroshi Abe, Noritomo Shimada, Yuta Aida, Munenori Itagaki, Yoshio Aizawa, Haruya Ishiguro, Keizo Kato
Publikováno v:
Journal of Medical Virology. 85:1523-1533
This study aimed to determine the most suitable duration of pegylated-interferon (Peg-IFN)-plus-ribavirin combination therapy in patients infected with hepatitis C virus (HCV) genotype 2 who had not achieved rapid virological response (serum HCV RNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a8aef75f7a2a48dcff290a20dbc16fc
https://doi.org/10.1002/jmv.23626
https://doi.org/10.1002/jmv.23626
Autor:
Noritomo Shimada, Yuta Aida, Haruya Ishiguro, Yoshio Aizawa, Makiko Ika, Hiroshi Abe, Akihito Tsubota, Kai Yoshizawa
Publikováno v:
Journal of Medical Virology. 85:1180-1190
Host lipoprotein metabolism is associated closely with the life cycle of hepatitis C virus (HCV), and serum lipid profiles have been linked to the response to pegylated interferon (Peg-IFN) plus ribavirin (RBV) therapy. Polymorphisms in the human IL2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8aa1eeaf8b9a5c40dae4eed3906d305d
https://doi.org/10.1002/jmv.23597
https://doi.org/10.1002/jmv.23597
C-Arm Cone Beam Computed Tomography Guidance for Radiofrequency Ablation in Hepatocellular Carcinoma
Autor:
Makiko Ika, Shinji Endo, Yoshiyuki Sato, Noriko Hanawa, Hiroshi Abe, Takeshi Yonezawa, Keizo Kato, Shohei Shimizu, Akihito Tsubota, Ryota Matsuo
Publikováno v:
Oncology. 92(3)
Objective: To assess the usefulness of C-arm cone beam computed tomography (CBCT) combined with ultrasound for the treatment of hepatocellular carcinoma (HCC) by radiofrequency ablation (RFA). Methods: Patients underwent RFA following transcatheter a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f9207595cbb754cbdd043ea3efbc5e9
https://pubmed.ncbi.nlm.nih.gov/28052301
https://pubmed.ncbi.nlm.nih.gov/28052301
Autor:
Tomomi Furihata, Norio Tada, Yoshihisa Namiki, Hiroshi Abe, Yoko Yumoto, Kiyotaka Fujise, Akihito Tsubota, Rie Agata, Yoshio Aizawa, Makiko Ika, Kai Yoshizawa, Noritomo Shimada, Kan Chiba
Publikováno v:
Liver International. 32:826-836
Background Standard-dose ribavirin is crucial for the standard-of-care treatment of chronic hepatitis C virus (HCV) infection. Equilibrative nucleoside transporter 1 (ENT1), encoded by SLC29A1 gene, is the main transporter that imports ribavirin into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f881395060f024657e1bb811524a2319
https://doi.org/10.1111/j.1478-3231.2011.02727.x
https://doi.org/10.1111/j.1478-3231.2011.02727.x
Autor:
Noritomo, Shimada, Akihito, Tsubota, Masanori, Atsukawa, Hiroshi, Abe, Tatsuya, Ide, Koichi, Takaguchi, Yoshimichi, Chuganji, Hidenori, Toyoda, Kai, Yoshizawa, Makiko, Ika, Yoshiyuki, Sato, Keizo, Kato, Takashi, Kumada, Choitsu, Sakamoto, Yoshio, Aizawa, Michio, Sata
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 44(14)
The sustained virological response (SVR) rate of non-responders to peginterferon and ribavirin therapy (PR) is low for 24-week telaprevir-based triple combination therapy (T12PR24), compared to that of treatment-naïve patients or previous-treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c763269f21fd13de7c14cc13f4739ca0
https://pubmed.ncbi.nlm.nih.gov/24606109
https://pubmed.ncbi.nlm.nih.gov/24606109